Outset Medical, Inc.

NASDAQ:OM

0.5941 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 27.38828.16830.50730.36236.0433.46732.00727.76125.05730.5528.15226.31825.21622.91617.24713.75611.7427.197.0852.632.8722.491
Cost of Revenue 17.60619.95322.79523.20528.33727.03926.73423.42521.27526.10824.83123.37224.16422.62716.8318.88216.50610.7549.8657.9247.3427.749
Gross Profit 9.7828.2157.7127.1577.7036.4285.2734.3363.7824.4423.3212.9461.0520.2890.417-5.126-4.764-3.564-2.78-5.294-4.47-5.258
Gross Profit Ratio 0.3570.2920.2530.2360.2140.1920.1650.1560.1510.1450.1180.1120.0420.0130.024-0.373-0.406-0.496-0.392-2.013-1.556-2.111
Reseach & Development Expenses 9.73412.63512.53216.07614.90613.79311.44413.05913.52110.83111.419.7298.0327.577.7849.1756.0535.8386.6295.7085.5835.407
General & Administrative Expenses 12.68411.44410.33911.81511.2911.78710.0221010.7849.7099.7197.6299.7229.2469.0513.0884.8483.5262.2782.4392.1862.016
Selling & Marketing Expenses 18.12821.04822.19424.7224.98524.33323.63122.27623.19820.37722.99115.72613.20413.14915.19813.3449.2447.2826.8835.0094.513.857
SG&A 30.81232.49232.53336.53536.27536.1233.65332.27633.98230.08632.7123.35522.92622.39524.24826.43214.09210.8089.1617.4486.6965.873
Other Expenses 0000000000000000000000
Operating Expenses 40.54645.12745.06552.61151.18149.91345.09745.33547.50340.91744.1233.08430.95829.96532.03235.60720.14516.64615.7913.15612.22910.846
Operating Income -30.764-36.912-37.353-45.454-43.478-43.485-39.824-40.999-43.721-36.475-40.799-30.138-29.906-29.676-31.615-40.733-24.909-20.21-18.57-18.45-16.749-16.538
Operating Income Ratio -1.123-1.31-1.224-1.497-1.206-1.299-1.244-1.477-1.745-1.194-1.449-1.145-1.186-1.295-1.833-2.961-2.121-2.811-2.621-7.015-5.832-6.639
Total Other Income Expenses Net -3.539-2.87-1.135-0.64-0.435-0.294-1.5560.238-0.022-0.302-0.308-0.332-0.267-0.31-0.428-1.13-0.6310.101-0.233.546-0.280.116
Income Before Tax -34.303-39.782-38.488-46.094-43.913-43.779-41.38-40.761-43.743-36.777-41.107-30.47-30.173-29.986-32.043-42.294-26.505-20.65-19.446-15.382-17.029-16.422
Income Before Tax Ratio -1.252-1.412-1.262-1.518-1.218-1.308-1.293-1.468-1.746-1.204-1.46-1.158-1.197-1.309-1.858-3.075-2.257-2.872-2.745-5.849-5.929-6.593
Income Tax Expense 0.1510.1620.1120.0860.1330.1920.0640.020.0960.1150.125-1.2140.0350.039-1.930.4311.0321.0011.020.028.0287.87
Net Income -34.454-39.944-38.6-46.18-44.046-43.971-41.444-40.781-43.839-36.892-41.232-30.47-30.208-30.025-32.043-42.294-26.505-20.65-19.446-15.402-25.057-24.292
Net Income Ratio -1.258-1.418-1.265-1.521-1.222-1.314-1.295-1.469-1.75-1.208-1.465-1.158-1.198-1.31-1.858-3.075-2.257-2.872-2.745-5.856-8.725-9.752
EPS -0.66-0.78-0.77-0.93-0.9-0.9-0.86-0.85-0.92-0.78-0.88-0.65-0.66-0.7-0.75-3.44-0.67-0.69-0.65-0.51-30.17-30.27
EPS Diluted -0.66-0.78-0.77-0.93-0.9-0.9-0.86-0.85-0.92-0.78-0.87-0.65-0.66-0.7-0.75-3.44-0.67-0.69-0.65-0.51-30.16-30.27
EBITDA -29.293-35.452-33.625-42.881-40.81-40.837-37.917-40.194-43.262-35.093-40.676-30.039-28.435-28.318-31.615-40.3-24.351-19.445-17.373-17.751-16.373-16.158
EBITDA Ratio -1.07-1.259-1.102-1.412-1.132-1.22-1.185-1.448-1.727-1.149-1.445-1.141-1.128-1.236-1.833-2.93-2.074-2.704-2.452-6.749-5.701-6.487